Tango Therapeutics, Inc. (TNGX) Net income 2020–2025
Tango Therapeutics, Inc. (TNGX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$101.6MFY2025 · since FY2020: -$52.0M → -$101.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$101.6M | +22.0% |
| FY2024 | -$130.3M | -28.1% |
| FY2023 | -$101.7M | +5.9% |
| FY2022 | -$108.2M | -85.8% |
| FY2021 | -$58.2M | -12.1% |
| FY2020 | -$52.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TNGX financial trends
TNGX RevenueTNGX Net marginTNGX Gross profitTNGX Gross marginTNGX Operating incomeTNGX Operating marginTNGX Operating cash flowTNGX Free cash flowTNGX Capital expendituresTNGX Return on equityTNGX Stock buybacksTNGX Dividends paidTNGX Total assetsTNGX Total liabilitiesTNGX Shareholders’ equityTNGX overview →